GENSAVIS PHARMACEUTICALS
Live / Registered — Registered (as of 08 Aug 2023)
What this means for you
Registered since 08 Aug 2023. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Aug 2029: the §8 declaration of use).
Record
- Serial number
- 97474628
- Registration number
- 7131102
- Mark type
- Design + words
- Filed
- 24 Jun 2022
- Published for opposition
- 23 May 2023
- Registered
- 08 Aug 2023
- Next maintenance filing
- §8 declaration of use, due by 08 Aug 2029 (grace period to 08 Feb 2030)
- Attorney of record
- David M. Sigmon
Goods and services
- Class 005 — Pharmaceuticals: Medicated and pharmaceutical preparations, namely, dietary supplements containing iron for humans
Owner
- Gensavis Pharmaceuticals, Inc., Greenville, TX, US
- Monsivais, LLC, Greenville, SC
- Monsivais, LLC, Greenville, SC
- Monsivais, LLC, Greenville, SC
Prosecution history
- 18 Nov 2025 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 27 Oct 2025 — NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
- 23 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 13 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Aug 2025 — POST REGISTRATION ACTION MAILED - SEC. 7
- 12 Aug 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Apr 2025 — TEAS SECTION 7 REQUEST RECEIVED
- 08 Aug 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Aug 2023 — REGISTERED-PRINCIPAL REGISTER
- 23 May 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 May 2023 — PUBLISHED FOR OPPOSITION
- 03 May 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Apr 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER